Hester Biosciences today reported 26.72 per cent rise in standalone net profit to Rs 9.01 crore for the March quarter, 2017-18.
It had posted net profit of Rs 7.11 crore for the January-March period of 2016-17, Hester Biosciences said in a filing to BSE.
The standalone net sales of the company rose to Rs 37.48 crore for the fourth quarter of last fiscal as against Rs 35.59 crore in the year-ago period.
For the entire 2017-18, the standalone net profit of Hester rose to Rs 30.55 crore. It was Rs 24.94 crore in the preceding fiscal.
Its net sales rose to Rs 135.25 crore for the fiscal ended March 2018. It was Rs 125.57 crore in 2016-17.
Total dividend for 2017-18 will be Rs 10 per equity share as against Rs 5.30 per equity share in 2016-17, the company said.
Shares of Hester Biosciences Ltd were trading 4.64 per cent at Rs 1,548.05 on BSE in the afternoon.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app